Timber Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Timber Pharmaceuticals has a total of 15 patents globally, out of which 6 have been granted. Of these 15 patents, more than 80% patents are active. United States of America is where Timber Pharmaceuticals has filed the maximum number of patents, followed by Australia and Mexico. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Timber Pharmaceuticals.

Timber Pharmaceuticals was founded in the year 2019. The Company operates as a biotech company. The Company develops treatments for rare skin diseases.

Do read about some of the most popular patents of Timber Pharmaceuticals which have been covered by us in this article and also you can find Timber Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Timber Pharmaceuticals patent portfolio.

How many patents does the founder and the CEO of Timber Pharmaceuticals have?

The founder Zachary Rome has 3 patents and CEO John Koconis has 0 patent.

How many patents does Timber Pharmaceuticals have?

Timber Pharmaceuticals has a total of 15 patents globally. These patents belong to 3 unique patent families. Out of 15 patents, 12 patents are active.

How Many Patents did Timber Pharmaceuticals File Every Year?

Timber Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantTimber Pharmaceuticals Applications FiledTimber Pharmaceuticals Patents Granted
20231
202222
202113
20201
20192
20182
20167

How many Timber Pharmaceuticals patents are Alive/Dead?

Timber Pharmaceuticals Patent Portfolio

 How Many Patents did Timber Pharmaceuticals File in Different Countries?

Timber Pharmaceuticals Worldwide Patent Filing

Countries in which Timber Pharmaceuticals Filed Patents

CountryPatents
United States Of America3
Australia2
Mexico2
China2
Hong Kong (S.A.R.)1
Canada1
Brazil1
Europe1

Where are Research Centres of Timber Pharmaceuticals Patents Located?

The Research Centre for all the Timber Pharmaceuticals patents is the United States of America.

What Percentage of Timber Pharmaceuticals US Patent Applications were Granted?

Timber Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.

Below are the key stats of Timber Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Timber Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Wiggin And Dana Llp20%

List of Timber Pharmaceuticals Patents

Timber Pharmaceuticals PatentsTitle
US11471408B2Isotretinoin Formulations And Uses And Methods Thereof
US10933018B2Isotretinoin Formulations And Uses And Methods Thereof
US20220362148A1Isotretinoin Formulations And Uses And Methods Thereof
EP3368009A1Isotretinoin Formulations And Uses And Methods Thereof
CN108348456BIsotretinoin Preparation And Its Use And Method
CN113577050AIsoretinoic Acid Formulations And Uses And Methods Thereof
AU2021206858B2Isotretinoin Formulations And Uses And Methods Thereof
AU2016346203B2Isotretinoin Formulations And Uses And Methods Thereof
CA3002387A1Isotretinoin Formulations And Uses Thereof
HK40057065AIsotretinoin Formulations And Uses And Methods Thereof
MX390018BIsotretinoin Formulations And Uses And Methods Thereof.
MX2022001772AIsotretinoin Formulations And Uses And Methods Thereof.
WO2019173219A1Compositions And Methods For Treating Pigmentation Disorders
WO2019173215A1Compositions And Methods For Treating Cutaneous Fibrosis
BR112018008556A2Pharmaceutical Compositions And Methods For Treatment Ichthyosis, Congenital

What are Timber Pharmaceuticals’ key innovation segments?

What Technologies are Covered by Timber Pharmaceuticals?

The chart below distributes patents filed by Timber Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Timber Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Timber Pharmaceuticals’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Timber Pharmaceuticals?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.